Unique device identifiers for coronary stent postmarket surveillance and research: a report from the Food and Drug Administration Medical Device Epidemiology Network Unique Device Identifier demonstration.
نویسندگان
چکیده
BACKGROUND Although electronic product identification in the consumer sector is ubiquitous, unique identification of medical devices is just being implemented in 2014. To evaluate unique device identifiers (UDIs) in health care, the US Food and Drug Administration (FDA) funded the Medical Device Epidemiology Network initiative, including a demonstration of the implementation of coronary stent UDI data in the information systems of a multihospital system (Mercy Health). This report describes the first phase of the demonstration. METHODS An expert panel of interventional cardiologists nominated by the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions was convened with representatives of industry, health system members of the Healthcare Transformation Group, the American College of Cardiology National Cardiovascular Data Registry, and FDA to articulate concepts needed to best use UDI-associated data. The expert panel identified 3: (1) use cases for UDI-associated data (eg, research), (2) a supplemental data set of clinically relevant attributes (eg, stent dimensions), and (3) governance and administrative principles for the authoritative management of these data. RESULTS Eighteen use cases were identified, encompassing clinical care, supply chain management, consumer information, research, regulatory, and surveillance domains. In addition to the attributes of the FDA Global Unique Device Identification Database, 9 additional coronary stent-specific attributes were required to address use case requirements. Recommendations regarding governance were elucidated as foundational principles for UDI-associated data management. CONCLUSIONS This process for identifying requisite extensions to support the effective use of UDI-associated data should be generalizable. Implementation of a UDI system for medical devices must anticipate both global and device-specific information.
منابع مشابه
Postmarket surveillance for drug-eluting coronary stents: a comprehensive approach.
The development and introduction of new medical devices have radically changed the practice of medicine. No area of medicine has been affected more than cardiology, with new devices facilitating the effective treatment of coronary artery disease (percutaneous coronary interventions [PCIs]/ stents), valvular heart disease (mechanical and bioprosthetic valves), and electrophysiological disorders ...
متن کاملNew FDA medical device rule imposes minimal burden on hospitals: facilities able to scan unique device identifiers will benefit.
New FDA rules on medical devices shouldn't be a burden for hospitals that can scan unique device identifiers.
متن کاملA New Stethoscope Design with Unique Characteristics and Development in Medical Device
As regards the significant role of stethoscopes in the diagnosis of congenital and adventitious heart diseases and prevention of irreparable complications of these diseases, the quality of hearing sound of these stethoscopes by a physician has a significant impact on the disease diagnosis. This device plays an important role in the early diagnosis of congenital heart and respiratory diseases an...
متن کاملBayesian adaptive design for device surveillance.
BACKGROUND Postmarket device surveillance studies often have important primary objectives tied to estimating a survival function at some future time $$T$$ with a certain amount of precision. PURPOSE This article presents the details and various operating characteristics of a Bayesian adaptive design for device surveillance, as well as a method for es...
متن کاملLeft to Their Own Devices: Breakdowns in United States Medical Device Premarket Review
Medical devices encompass nearly every medical product that does not achieve its intended purpose through chemical action, from the simple (tongue blades) to the complex (MRI machines), and from the safe (stethoscopes) to the risky (artificial hearts) [1,2]. Certain drug–device combinations, such as drug-eluting coronary stents, are also regulated as devices. The number and complexity of medica...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- American heart journal
دوره 168 4 شماره
صفحات -
تاریخ انتشار 2014